医薬品リファレンス
Risankizumab
Risankizumab is a medicine in the class miscellaneous. It is used for crohn's disease.
- 薬効分類: Miscellaneous
- 効能・効果: crohn's disease
最終更新日 出典: US FDA label
医療従事者向け・参照専用。このページは簡潔な要約であり、医学的助言ではなく、公式の添付文書や臨床判断に代わるものではありません。処方・調剤の前に必ず確認してください。
このページの臨床コンテンツは英語でのみ提供されています。
要点
- 薬効分類
- Miscellaneous
- ATCコード
- L04AC18
- 一般的な剤形
- 注射剤
- 一般的な規格
- 150 mg/ml
- 既知の相互作用
- 2 (重大: 1 · 中等度: 1)
- 商品名
- 3
- 国・市場
- 3
何に使われるか
作用のしくみ
Humanized IgG1 monoclonal antibody that selectively binds the p19 subunit of human IL-23 and inhibits its interaction with the IL-23 receptor, reducing release of pro-inflammatory cytokines and chemokines.
成人の通常用量（添付文書の要約）
Plaque psoriasis: 150 mg, subcutaneous injection, at Week 0, Week 4, and every 12 weeks thereafter
妊娠と授乳
- 妊娠
- Unknown Data are insufficient to show a risk; a registry exists. Antibodies cross the placenta, mainly late in pregnancy, and may suppress the infant's immunity. Monkeys had more fetal and infant deaths at high doses. Use only if needed; delay live vaccines in exposed infants.
- 授乳
- Safe No human milk data. A large antibody: milk levels are likely very low and it is probably digested in the infant's gut. Some expert guidelines consider it acceptable while breastfeeding (LactMed). US label: weigh benefits.
報告されている副作用
- Upper respiratory infections
- Headache
- Fatigue
- Injection site reactions
- Tinea infections
- Arthralgia
禁忌
- History of serious hypersensitivity reaction to risankizumab-rzaa or any excipients.
注意が必要な方
- Serious hypersensitivity reactions including anaphylaxis may occur; discontinue and treat immediately if it occurs.
- May increase risk of infection; do not start in clinically important active infection and withhold if one develops until resolved.
- Evaluate for TB before initiating; do not give to patients with active TB; monitor for TB signs during and after treatment.
妊娠中または授乳中であること、腎臓や肝臓の病気、アレルギー、ほかに使用しているすべての薬やサプリメントについて、薬剤師または医師にお伝えください。
主な相互作用 (2)
Pro+会員向け
ページ全体を見る
アカウントを作成してPro+トライアルを始めると、Risankizumabの完全なモノグラフ（用量、妊娠・授乳、副作用、警告、すべての相互作用）を表示できます。
- Dosing by age, kidney and liver function, and further dose lines
- Renal and hepatic dose adjustments
- Paediatric dosing
- Dosing in older adults
- How to give it
- Pharmacokinetics
- Patient counselling points
- IV preparation and dilution
WebでPro+を14日間無料でお試し。カード登録不要。
同じ分類のほかの薬剤
関連するクイックリード
よくある質問
What is Risankizumab used for?
Risankizumab is a medicine in the class miscellaneous. It is used for Crohn's disease, Plaque psoriasis, Psoriatic arthritis, Ulcerative colitis.
What side effects have been reported with Risankizumab?
Upper respiratory infections, Headache, Fatigue, Injection site reactions, Tinea infections, Arthralgia.
Can Risankizumab be taken in pregnancy or while breastfeeding?
Pregnancy: Unknown. Data are insufficient to show a risk; a registry exists. Antibodies cross the placenta, mainly late in pregnancy, and may suppress the infant's immunity. Monkeys had more fetal and infant deaths at high doses. Use only if needed; delay live vaccines in exposed infants. Breastfeeding: Safe. No human milk data. A large antibody: milk levels are likely very low and it is probably digested in the infant's gut. Some expert guidelines consider it acceptable while breastfeeding (LactMed). US label: weigh benefits.
What does Risankizumab interact with?
MediHelp lists 2 known interactions for Risankizumab. Major: 1 · Moderate: 1. The most serious include Upadacitinib, Measles mumps and rubella vaccine.
完全なモノグラフ、用量、相互作用チェッカーはMediHelpアプリで
MediHelpアプリで、完全なリファレンスを開き、複数薬剤の相互作用をチェックし、用量ツールを利用できます。
